- Release Date: 13/12/17 08:24
- Summary: Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit
- Price Sensitive: Yes
- Download Document 152.19KB
Ann: Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.8¢ |
Change
-0.003(1.25%) |
Mkt cap ! $87.89M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.8¢ | 19.5¢ | $29.82K | 151.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 510946 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 803554 | 8 |
View Market Depth
| Last trade - 11.53am 10/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |